LEADER 03479nam  2200913z- 450 
001 9910576881103321
005 20220621
035   $a(CKB)5720000000008364
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/84476
035   $a(oapen)doab84476
035   $a(EXLCZ)995720000000008364
100   $a20202206d2022      |y         0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDiabetology: Feature Papers 2021
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 online resource (158 p.)
311 08$a3-0365-4159-4 
311 08$a3-0365-4160-8 
330   $aAs Editor-in-Chief of the journal Diabetology, I am pleased to announce the Special Issue "Diabetology: Feature Papers 2021" is now published in book format. Diabetology (ISSN 2673-4540) is an international, peer-reviewed scientific open access journal that provides an advanced forum for studies related to epidemiology, etiology, pathophysiology, pathogenesis, management, complications, and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. In this Special Issue, "Feature Papers", we aim to publish outstanding contributions in the main fields covered by the journal, which will make a great contribution to the community. This book covers the whole spectrum of diabetology from risk screening, risk markers, pathways of disease in type 1 diabetes and insulin treatment, and management of the disease and comorbidities.
517   $aDiabetology
606   $aMedicine$2bicssc
610   $aACE2
610   $aautoimmune diseases
610   $abanting
610   $abest
610   $ablood glucose monitoring
610   $acarpal tunnel syndrome
610   $achronic kidney disease (CKD)
610   $acollip
610   $acontinuous blood glucose sensors
610   $aCOVID-19
610   $aCOVID-associated mucormycosis (CAM)
610   $adiabetes
610   $aDiabetic Keto Acidosis (DKA)
610   $adiabetic nephropathy
610   $aferroptosis
610   $aFINDRISC
610   $afocus groups
610   $ahealthcare professionals
610   $aimmunotherapy
610   $ainsulin
610   $ainsulin pumps
610   $alimited-resource countries (LRC)
610   $aMacLeod
610   $ameta-analysis
610   $ametabolic syndrome
610   $aMetabolic-Stress-Associated Interactome (MSAI)
610   $amiddle-aged population
610   $amucins
610   $amucormycosis
610   $aN-acetyl-?-d-glucosaminidase (NAG)
610   $an/a
610   $aolfactory neurovascular niche
610   $apancreatic ?-cells
610   $apatients' experiences
610   $apower doppler signal
610   $aprediabetes
610   $aredox-iron stress
610   $aregulatory T cells
610   $aSARS-CoV-2
610   $aself-management of type 2 diabetes
610   $aserine proteases
610   $asystematic review
610   $aTMPRSS2
610   $atolerance
610   $atype 1 diabetes
610   $aultrasound
610   $ayoung-adults
615  7$aMedicine
700   $aClifton$b Peter$4edt$0545914
702   $aClifton$b Peter$4oth
906   $aBOOK
912   $a9910576881103321
996   $aDiabetology: Feature Papers 2021$93021751
997   $aUNINA